<VariationArchive VariationID="1703957" VariationName="NM_005629.4(SLC6A8):c.1519_1543del (p.Ile507fs)" VariationType="Deletion" Accession="VCV001703957" Version="4" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-20" DateCreated="2022-09-10" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1696434" VariationID="1703957">
      <GeneList>
        <Gene Symbol="SLC6A8" FullName="solute carrier family 6 member 8" GeneID="6535" HGNC_ID="HGNC:11055" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153687926" stop="153696593" display_start="153687926" display_stop="153696593" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152953751" stop="152962047" display_start="152953751" display_stop="152962047" Strand="+" />
          </Location>
          <OMIM>300036</OMIM>
          <Haploinsufficiency last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC6A8">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC6A8">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_005629.4(SLC6A8):c.1519_1543del (p.Ile507fs)</Name>
      <CanonicalSPDI>NC_000023.11:153694551:CGACATTGCCTGTATGATCGGGTACCGAC:CGAC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153694552" stop="153694576" display_start="153694552" display_stop="153694576" variantLength="25" positionVCF="153694551" referenceAlleleVCF="ACGACATTGCCTGTATGATCGGGTAC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152960007" stop="152960031" display_start="152960007" display_stop="152960031" variantLength="25" positionVCF="152960006" referenceAlleleVCF="ACGACATTGCCTGTATGATCGGGTAC" alternateAlleleVCF="A" />
      </Location>
      <OtherNameList>
        <Name>NM_005629.4(SLC6A8):c.1519_1543del</Name>
        <Name>p.Ile507fs</Name>
      </OtherNameList>
      <ProteinChange>I392fs</ProteinChange>
      <ProteinChange>I497fs</ProteinChange>
      <ProteinChange>I507fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.152960011_152960035del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.152960011_152960035del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.153694556_153694580del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.153694556_153694580del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012016.2" sequenceAccession="NG_012016" sequenceVersion="2" change="g.11260_11284del">
            <Expression>NG_012016.2:g.11260_11284del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001142805.2" sequenceAccession="NM_001142805" sequenceVersion="2" change="c.1489_1513del">
            <Expression>NM_001142805.2:c.1489_1513del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001136277.1" sequenceAccession="NP_001136277" sequenceVersion="1" change="p.Ile497fs">
            <Expression>NP_001136277.1:p.Ile497fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001142806.1" sequenceAccession="NM_001142806" sequenceVersion="1" change="c.1174_1198del">
            <Expression>NM_001142806.1:c.1174_1198del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001136278.1" sequenceAccession="NP_001136278" sequenceVersion="1" change="p.Ile392fs">
            <Expression>NP_001136278.1:p.Ile392fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005629.4" sequenceAccession="NM_005629" sequenceVersion="4" change="c.1519_1543del" MANESelect="true">
            <Expression>NM_005629.4:c.1519_1543del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005620.1" sequenceAccession="NP_005620" sequenceVersion="1" change="p.Ile507fs">
            <Expression>NP_005620.1:p.Ile507fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005629.4(SLC6A8):c.1519_1543del (p.Ile507fs) AND not provided" Accession="RCV002281292" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-04-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005629.4(SLC6A8):c.1519_1543del (p.Ile507fs) AND Creatine transporter deficiency" Accession="RCV003334068" Version="2">
        <ClassifiedConditionList TraitSetID="3187">
          <ClassifiedCondition DB="MedGen" ID="C1845862">Creatine transporter deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2023-08-10" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-10" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2022-09-10" MostRecentSubmission="2024-02-20">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21660517</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22281021</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/e33f15c9-68d0-4c2b-8ae6-38a4c9e7fb26</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="3187" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1686" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CREATINE TRANSPORTER DEFECT</ElementValue>
                <XRef Type="MIM" ID="300352" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CEREBRAL CREATINE DEFICIENCY SYNDROME 1</ElementValue>
                <XRef Type="MIM" ID="300352" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0010" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Creatine transporter deficiency</ElementValue>
                <XRef ID="MONDO:0010305" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Creatine deficiency, X-linked</ElementValue>
                <XRef ID="Creatine+Deficiency%2C+X-Linked/2001" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation , X-linked with seizures, short stature and midface hypoplasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation , X-linked, with creatine transport deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked creatine transporter deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked creatine deficiency syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SLC6A8-Related Creatine Transporter Deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CCDS1</ElementValue>
                <XRef Type="MIM" ID="300352" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1608" />
                <XRef ID="1608" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The creatine deficiency disorders (CDDs), inborn errors of creatine metabolism and transport, comprise three disorders: the creatine biosynthesis disorders guanidinoacetate methyltransferase (GAMT) deficiency and L-arginine:glycine amidinotransferase (AGAT) deficiency; and creatine transporter (CRTR) deficiency. Developmental delay and cognitive dysfunction or intellectual disability and speech-language disorder are common to all three CDDs. Onset of clinical manifestations of GAMT deficiency (reported in ~130 individuals) is between ages three months and two years; in addition to developmental delays, the majority of individuals have epilepsy and develop a behavior disorder (e.g., hyperactivity, autism, or self-injurious behavior), and about 30% have movement disorder. AGAT deficiency has been reported in 16 individuals; none have had epilepsy or movement disorders. Clinical findings of CRTR deficiency in affected males (reported in ~130 individuals) in addition to developmental delays include epilepsy (variable seizure types and may be intractable) and behavior disorders (e.g., attention deficit and/or hyperactivity, autistic features, impulsivity, social anxiety), hypotonia, and (less commonly) a movement disorder. Poor weight gain with constipation and prolonged QTc on EKG have been reported. While mild-to-moderate intellectual disability is commonly observed up to age four years, the majority of adult males with CRTR deficiency have been reported to have severe intellectual disability. Females heterozygous for CRTR deficiency are typically either asymptomatic or have mild intellectual disability, although a more severe phenotype resembling the male phenotype has been reported.</Attribute>
                <XRef ID="NBK3794" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301745</ID>
                <ID Source="BookShelf">NBK3794</ID>
              </Citation>
              <XRef ID="52503" DB="Orphanet" />
              <XRef ID="C1845862" DB="MedGen" />
              <XRef ID="MONDO:0010305" DB="MONDO" />
              <XRef Type="MIM" ID="300352" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5024557" SubmissionDate="2022-09-07" DateLastUpdated="2023-03-04" DateCreated="2022-09-10">
        <ClinVarSubmissionID localKey="GDXSV:238244" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002569484" DateUpdated="2023-03-04" DateCreated="2022-09-10" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 23234264, 23534590, Valongo2017[Case Report], 21660517)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC6A8" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:5132498</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005629.3:c.1519_1543del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_128_20220907054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="7565766" SubmissionDate="2023-10-13" DateLastUpdated="2023-10-14" DateCreated="2023-10-14">
        <ClinVarSubmissionID localKey="e33f15c9-68d0-4c2b-8ae6-38a4c9e7fb26" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004042593" DateUpdated="2023-10-14" DateCreated="2023-10-14" Type="SCV" Version="1" SubmitterName="ClinGen Cerebral Creatine Deficiency Syndromes Variant Curation Expert Panel, ClinGen" OrgID="508816" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-10">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/e33f15c9-68d0-4c2b-8ae6-38a4c9e7fb26</URL>
          </Citation>
          <Comment>The NM_005629.4:c.1519_1543del (p.Ile507LeufsTer5) variant in SLC6A8 is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 11/13 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant has been reported in a male proband with elevated urine creatine/creatinine and reduced creatine peak on brain MRS (PP4_Strong) and was found to be a de novo variant in this individual (PS2) (PMID: 23534590). This variant has also been reported in two additional unrelated male probands (PMID: 21660517, PMID: 23234264) (PS4_Moderate). The variant is absent in gnomAD v2.1.1. (PM2_Supporting). There is a ClinVar entry for this variant (Variation ID: 1703957). In summary, this variant meets criteria to be classified as pathogenic for creatine transporter deficiency. SLC6A8-specific criteria applied, as specified by the ClinGen CCDS VCEP (Specifications Version 1.1.0): PVS1, PS2, PS4_Moderate, PM2_Supporting, PP4_Strong. (Classification approved by the ClinGen CCDS VCEP: August 10, 2023)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen_CCDS_ACMG_Specifications_SLC6A8_v1.1</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/qrdrqmt7/clingen_ccds_acmg_specifications_slc6a8_v1.1.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC6A8" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_005629.4(SLC6A8):c.1519_1543del</Name>
            <Name>p.Ile507fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.11:g.153694556_153694580del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0010305" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13899592</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8325018" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="9712692|MedGen:C1845862" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004535507" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21660517</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22281021</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1703957). This premature translational stop signal has been observed in individual(s) with clinical features of creatine transporter deficiency (PMID: 21660517). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ile507Leufs*5) in the SLC6A8 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC6A8 are known to be pathogenic (PMID: 22281021).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC6A8" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.152960007_152960031del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1845862" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5024557" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8325018" TraitType="Disease" MappingType="XRef" MappingValue="C1845862" MappingRef="MedGen">
        <MedGen CUI="C1845862" Name="Creatine transporter deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7565766" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0010305" MappingRef="MONDO">
        <MedGen CUI="C1845862" Name="Creatine transporter deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

